Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2016 Apr 15;59(6):615–621. doi: 10.1007/s11427-016-5038-1

Genetic and antigenic characterization of recombinant nucleocapsid proteins derived from canine coronavirus and canine respiratory coronavirus in China

Shuai Lu 1, Yingzhu Chen 1, Kun Qin 2, Jianfang Zhou 2, Yongliang Lou 1, Wenjie Tan 1,2,✉
PMCID: PMC7089282  PMID: 27084706

Abstract

To characterize the antigenicity of nucleocapsid proteins (NP) derived from canine coronavirus (CCoV) and canine respiratory coronavirus (CRCoV) in China, the N genes of CCoV (CCoV-BJ70) and CRCoV (CRCoV-BJ202) were cloned from swabs obtained from diseased pet dogs in Beijing and then sequenced. The recombinant NPs (rNPs) were expressed in Escherichia coli and purified by nickel-affinity column and size exclusion chromatography. Sequencing data indicated that the N genes of CCoV-BJ70 and CRCoV-BJ202 belonging to two distinctly different groups were relatively conserved within each subgroup. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) results showed that rNPs of CCoV and CRCoV were expressed efficiently and isolated with a final purity of over 95%. Western blot analysis revealed the rNP from CRCoV could cross-react with mice antisera against human coronavirus (HCoV-229E, NL63, OC43, HKU1), while rNP of CCoV had cross-reactivity with only anti-sera against viruses belonging to the same group (HCoV-229E and NL63). In summary, CCoV and CRCoV rNPs were successfully expressed in E. coli and showed antigenic cross-reactivity with antisera raised against human coronaviruses. These findings indicate that further serologic studies on coronavirus infections at the animal-human interface are needed.

Keywords: canine coronavirus, canine respiratory coronavirus, nucleocapsid protein, expression, cross-reactivity

Footnotes

This article is published with open access at link.springer.com

References

  1. Belouzard S., Millet J.K., Licitra B.N., Whittaker G.R. Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses. 2012;4:1011–1033. doi: 10.3390/v4061011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Binn L., Lazar E., Keenan K., Huxsoll D., Marchwicki R., Strano A. Recovery and characterization of a coronavirus from military dogs with diarrhea. Proccedings of the Annual Meeting of the USA Animal Health Assoc. 1974;78:359–366. [PubMed] [Google Scholar]
  3. Che X., Hao W., Wang Y., Di B., Yin K., Xu Y., Feng C., Wan Z., Cheng V.C.C., Yuen K. Nucleocapsid protein as early diagnostic marker for SARS. Emerg Infect Dis. 2004;10:11947–11949. doi: 10.3201/eid1011.040516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Costa E.M., de Castro T.X., Bottino Fde O., Garcia Rde C. Molecular characterization of canine coronavirus strains circulating in Brazil. Vet Microbiol. 2014;168:8–15. doi: 10.1016/j.vetmic.2013.10.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Erles K., Brownlie J. Sequence analysis of divergent canine coronavirus strains present in a UKdog population. Virus Res. 2009;141:21–25. doi: 10.1016/j.virusres.2008.12.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Erles K., Toomey C., Brooks H.W., Brownlie J. Detection of a group 2 coronavirus in dogs with canine infectious respiratory disease. Virology. 2003;310:216–223. doi: 10.1016/S0042-6822(03)00160-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gao F., Hu G., Xia X., Gao Y., Bai Y., Zou X. Isolation and identification of a canine coronavirus strain from giant pandas (Ailuropoda melanoleuca) J Vet Sci. 2009;10:261. doi: 10.4142/jvs.2009.10.3.261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kong Q. Progress on immune prevention of canine coronavirus disease (in Chinese) Prog Vet Med. 2007;28:72–76. [Google Scholar]
  9. Li Y., Li J., Liu X., Wang L., Li T., Zhou Y., Zhuang H. Detection of the nucleocapsid protein of severe acute respiratory syndrome coronavirus in serum: comparison with results of other viral markers. J Virol Methods. 2005;130:45–50. doi: 10.1016/j.jviromet.2005.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lorusso A., Desario C., Mari V., Campolo M., Lorusso E., Elia G., Martella V., Buonavoglia C., Decaro N. Molecular characterization of a canine respiratory coronavirus strain detected in Italy. Virus Res. 2009;141:96–100. doi: 10.1016/j.virusres.2008.12.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Naylor M.J., Walia C.S., McOrist S., Lehrbach P.R., Deane E.M., Harrison G.A. Molecular characterization confirms the presence of a divergent strain of canine coronavirus (UWSMN-1) in Australia. J Clin Microbiol. 2002;40:3518–3522. doi: 10.1128/JCM.40.9.3518-3522.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Decaro N., Buonavoglia C. An update on canine coronaviruses: viral evolution and pathobiology. Vet Microbiol. 2008;132:221–234. doi: 10.1016/j.vetmic.2008.06.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Peiris J.S.M., Lai S.T., Poon L.L.M., Guan Y., Yam L.Y.C., Lim W., Nicholls J., Yee W.K.S., Yan W.W., Cheung M.T., Cheng V.C.C., Chan K.H., Tsang D.N.C., Yung R.W.H., Ng T.K., Yuen K.Y. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003;361:1319–1325. doi: 10.1016/S0140-6736(03)13077-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Shi Y., Yi Y., Li P., Kuang T., Li L., Dong M., Ma Q., Cao C. Diagnosis of severe acute respiratory syndrome (SARS) by de tection of SARS coronavirus nucleocapsid antibodies in an antigen-capturing enzyme-linked immunosorbent assay. J Clin Microbiol. 2003;41:5781–5782. doi: 10.1128/JCM.41.12.5781-5782.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sudhakar A., Robin G., Boyd L.Y., Eric F.D., Vineet D.M., Rachel L.G., Trevor D.S., Lisa E.G., Mark R.D., Maria Z., Baric R.S. Evaluation of serologic and antigenic relationships between Middle Eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses. J Infect Dis. 2014;209:995–1006. doi: 10.1093/infdis/jit609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Sun Z., Meng J. Antigenic cross-reactivity between the nucleocapsid protein of severe acute respiratory syndrome (SARS) coronavirus and polyclonal antisera of antigenic group I animal coronaviruses_implication for SARS diagnosis. J Clin Microbiol. 2004;42:2351–2352. doi: 10.1128/JCM.42.5.2351-2352.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Tan Y., Goh P., Fielding B., Shen S., Chou C., Fu J., Leong H., Leo Y., Ooi E., Ling A., Lim S.G., Hong W. Profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers. Clin Diagn Lab Immunol. 2004;11:362–371. doi: 10.1128/CDLI.11.2.362-371.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Vlasova A.N., Zhang X., Hasoksuz M., Nagesha H.S., Haynes L.M., Fang Y., Lu S., Saif L.J. Two-way antigenic cross-reactivity between severe acute respiratory syndrome coronavirus (SARS-CoV) and group 1 animal CoVs is mediated through an antigenic site in the N-terminal region of the SARS-CoV nucleoprotein. J Virol. 2007;81:13365–13377. doi: 10.1128/JVI.01169-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Woo P.C., Lau S.K., Huang Y., Yuen K.Y. Coronavirus diversity, phylogeny and interspecies jumping. Exp Biol Med. 2009;234:1117–1127. doi: 10.3181/0903-MR-94. [DOI] [PubMed] [Google Scholar]
  20. Yachi A., Mochizuki M. Survey of dogs in Japan for group 2 canine coronavirus infection. J Clin Microbiol. 2006;44:2615–2618. doi: 10.1128/JCM.02397-05. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Science China. Life Sciences are provided here courtesy of Nature Publishing Group

RESOURCES